Cargando…
Molecular Insights into the In Vivo Analgesic and Anti-Inflammatory Activity of Indomethacin Analogues
[Image: see text] The primary objective of this research was to identify and explore the most potent and efficacious cyclooxygenase inhibitors, utilizing indole acetic acid drugs as a lead molecule. To achieve this objective, various derivatives (2a–2c and 2e–2g) of the selected lead molecule, indom...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448495/ https://www.ncbi.nlm.nih.gov/pubmed/37636936 http://dx.doi.org/10.1021/acsomega.3c02033 |
_version_ | 1785094746089193472 |
---|---|
author | Ahmad, Abid Ali Hussain, Kashif Shah, Muhammad Raza Ashhad Halimi, Syed Muhammad Rabbi, Fazle Ahmad, Zahoor Khan, Inamullah Rauf, Abdur Alshammari, Abdulrahman Alharbi, Metab Rasul Suleria, Hafiz Ansar |
author_facet | Ahmad, Abid Ali Hussain, Kashif Shah, Muhammad Raza Ashhad Halimi, Syed Muhammad Rabbi, Fazle Ahmad, Zahoor Khan, Inamullah Rauf, Abdur Alshammari, Abdulrahman Alharbi, Metab Rasul Suleria, Hafiz Ansar |
author_sort | Ahmad, Abid Ali |
collection | PubMed |
description | [Image: see text] The primary objective of this research was to identify and explore the most potent and efficacious cyclooxygenase inhibitors, utilizing indole acetic acid drugs as a lead molecule. To achieve this objective, various derivatives (2a–2c and 2e–2g) of the selected lead molecule, indomethacin, were synthesized using a reflux condensation process, targeting the hydroxyl group. The synthesized analogues were subjected to different spectroscopic procedures to determine their structure and confirm their analogues. These derivatives were further screened for acute toxicity and anti-nociceptive and anti-inflammatory activity using established protocols. Docking analysis was performed to evaluate the possible protein–ligand interaction. The test compounds were found to be safe at doses of 50, 75, 100, and 200 mg/kg, i.p. The pharmacological screening revealed that test compounds 2a–2f had a superior peripheral analgesic effect at a dose of 10 mg/kg, in comparison to the parent drug indomethacin, while compound 2g exhibited slightly lower activity at the same dose. The hot plate results showed lower central analgesic activity of the test compounds compared to the standard Tramal, but it was still significant. Anti-inflammatory results were significant, comparable to Diclofenac sodium and indomethacin, except for compounds 2b, 2c, and 2e at a dose of 10 mg/kg body weight. Molecular docking analysis demonstrated that the derived compounds had augmented negative binding energies (−149.39, −146.72, −160.85, −159.34, −140.03, and −150.91 KJ/mol) compared to the parent drugs (−141.07), which supported the research’s theme of producing stronger derivatives of standard drugs with significant anti-nociceptive and anti-inflammatory potential. The derived compounds exhibited significant analgesic and anti-inflammatory activities and, therefore, have the potential to be studied further as new drug candidates for pain and inflammation. |
format | Online Article Text |
id | pubmed-10448495 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-104484952023-08-25 Molecular Insights into the In Vivo Analgesic and Anti-Inflammatory Activity of Indomethacin Analogues Ahmad, Abid Ali Hussain, Kashif Shah, Muhammad Raza Ashhad Halimi, Syed Muhammad Rabbi, Fazle Ahmad, Zahoor Khan, Inamullah Rauf, Abdur Alshammari, Abdulrahman Alharbi, Metab Rasul Suleria, Hafiz Ansar ACS Omega [Image: see text] The primary objective of this research was to identify and explore the most potent and efficacious cyclooxygenase inhibitors, utilizing indole acetic acid drugs as a lead molecule. To achieve this objective, various derivatives (2a–2c and 2e–2g) of the selected lead molecule, indomethacin, were synthesized using a reflux condensation process, targeting the hydroxyl group. The synthesized analogues were subjected to different spectroscopic procedures to determine their structure and confirm their analogues. These derivatives were further screened for acute toxicity and anti-nociceptive and anti-inflammatory activity using established protocols. Docking analysis was performed to evaluate the possible protein–ligand interaction. The test compounds were found to be safe at doses of 50, 75, 100, and 200 mg/kg, i.p. The pharmacological screening revealed that test compounds 2a–2f had a superior peripheral analgesic effect at a dose of 10 mg/kg, in comparison to the parent drug indomethacin, while compound 2g exhibited slightly lower activity at the same dose. The hot plate results showed lower central analgesic activity of the test compounds compared to the standard Tramal, but it was still significant. Anti-inflammatory results were significant, comparable to Diclofenac sodium and indomethacin, except for compounds 2b, 2c, and 2e at a dose of 10 mg/kg body weight. Molecular docking analysis demonstrated that the derived compounds had augmented negative binding energies (−149.39, −146.72, −160.85, −159.34, −140.03, and −150.91 KJ/mol) compared to the parent drugs (−141.07), which supported the research’s theme of producing stronger derivatives of standard drugs with significant anti-nociceptive and anti-inflammatory potential. The derived compounds exhibited significant analgesic and anti-inflammatory activities and, therefore, have the potential to be studied further as new drug candidates for pain and inflammation. American Chemical Society 2023-08-10 /pmc/articles/PMC10448495/ /pubmed/37636936 http://dx.doi.org/10.1021/acsomega.3c02033 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Ahmad, Abid Ali Hussain, Kashif Shah, Muhammad Raza Ashhad Halimi, Syed Muhammad Rabbi, Fazle Ahmad, Zahoor Khan, Inamullah Rauf, Abdur Alshammari, Abdulrahman Alharbi, Metab Rasul Suleria, Hafiz Ansar Molecular Insights into the In Vivo Analgesic and Anti-Inflammatory Activity of Indomethacin Analogues |
title | Molecular Insights
into the In Vivo Analgesic and Anti-Inflammatory
Activity of Indomethacin Analogues |
title_full | Molecular Insights
into the In Vivo Analgesic and Anti-Inflammatory
Activity of Indomethacin Analogues |
title_fullStr | Molecular Insights
into the In Vivo Analgesic and Anti-Inflammatory
Activity of Indomethacin Analogues |
title_full_unstemmed | Molecular Insights
into the In Vivo Analgesic and Anti-Inflammatory
Activity of Indomethacin Analogues |
title_short | Molecular Insights
into the In Vivo Analgesic and Anti-Inflammatory
Activity of Indomethacin Analogues |
title_sort | molecular insights
into the in vivo analgesic and anti-inflammatory
activity of indomethacin analogues |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448495/ https://www.ncbi.nlm.nih.gov/pubmed/37636936 http://dx.doi.org/10.1021/acsomega.3c02033 |
work_keys_str_mv | AT ahmadabidali molecularinsightsintotheinvivoanalgesicandantiinflammatoryactivityofindomethacinanalogues AT hussainkashif molecularinsightsintotheinvivoanalgesicandantiinflammatoryactivityofindomethacinanalogues AT shahmuhammadraza molecularinsightsintotheinvivoanalgesicandantiinflammatoryactivityofindomethacinanalogues AT ashhadhalimisyedmuhammad molecularinsightsintotheinvivoanalgesicandantiinflammatoryactivityofindomethacinanalogues AT rabbifazle molecularinsightsintotheinvivoanalgesicandantiinflammatoryactivityofindomethacinanalogues AT ahmadzahoor molecularinsightsintotheinvivoanalgesicandantiinflammatoryactivityofindomethacinanalogues AT khaninamullah molecularinsightsintotheinvivoanalgesicandantiinflammatoryactivityofindomethacinanalogues AT raufabdur molecularinsightsintotheinvivoanalgesicandantiinflammatoryactivityofindomethacinanalogues AT alshammariabdulrahman molecularinsightsintotheinvivoanalgesicandantiinflammatoryactivityofindomethacinanalogues AT alharbimetab molecularinsightsintotheinvivoanalgesicandantiinflammatoryactivityofindomethacinanalogues AT rasulsuleriahafizansar molecularinsightsintotheinvivoanalgesicandantiinflammatoryactivityofindomethacinanalogues |